Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Endonovo Therapeutics's gross profit for the twelve months ending Sep 30, 2023 was $246.03K, up 110229.1% year over year. For fiscal 2022 it was $125.37K, up 115.7% from the year before. The highest annual figure on record is $216.78K in fiscal 2019.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $125.37K | +115.7% |
| FY2021 | Dec 31, 2021 | $58.12K | -42.1% |
| FY2020 | Dec 31, 2020 | $100.43K | -53.7% |
| FY2019 | Dec 31, 2019 | $216.78K | +208.2% |
| FY2018 | Dec 31, 2018 | $70.33K | +3244.4% |
| FY2015 | Dec 31, 2015 | $2.10K | -75.8% |
| FY2014 | Dec 31, 2014 | $8.71K | -2.2% |
| FY2013 | Dec 31, 2013 | $8.90K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $693 | -90.0% |
| Q2 FY2023 | Jun 30, 2023 | $45.20K | +16828.8% |
| Q1 FY2023 | Mar 31, 2023 | $83.54K | +5228.1% |
| Q4 FY2022 | Dec 31, 2022 | $116.60K | – |
| Q3 FY2022 | Sep 30, 2022 | $6.93K | +47.9% |
| Q2 FY2022 | Jun 30, 2022 | $267 | -99.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.57K | -95.1% |
| Q4 FY2021 | Dec 31, 2021 | -$8.55K | – |
| Q3 FY2021 | Sep 30, 2021 | $4.69K | -88.0% |
| Q2 FY2021 | Jun 30, 2021 | $29.78K | -10.6% |
| Q1 FY2021 | Mar 31, 2021 | $32.19K | -49.2% |
| Q4 FY2020 | Dec 31, 2020 | -$35.55K | -135.1% |
| Q3 FY2020 | Sep 30, 2020 | $39.22K | -13.1% |
| Q2 FY2020 | Jun 30, 2020 | $33.33K | +0.5% |
| Q1 FY2020 | Mar 31, 2020 | $63.43K | +70.3% |
| Q4 FY2019 | Dec 31, 2019 | $101.27K | +197.3% |
| Q3 FY2019 | Sep 30, 2019 | $45.11K | +165.5% |
| Q2 FY2019 | Jun 30, 2019 | $33.16K | +169.5% |
| Q1 FY2019 | Mar 31, 2019 | $37.24K | +434.2% |
| Q4 FY2018 | Dec 31, 2018 | $34.06K | +1673.2% |
| Q3 FY2018 | Sep 30, 2018 | $16.99K | – |
| Q2 FY2018 | Jun 30, 2018 | $12.30K | +155.6% |
| Q1 FY2018 | Mar 31, 2018 | $6.97K | -33.7% |
| Q1 FY2015 | Mar 31, 2015 | $1.92K | -79.4% |
| Q4 FY2014 | Dec 31, 2014 | -$15.93K | – |
| Q3 FY2014 | Sep 30, 2014 | $4.81K | – |
| Q2 FY2014 | Jun 30, 2014 | $10.51K | – |
| Q1 FY2014 | Mar 31, 2014 | $9.31K | – |
See a number that looks wrong?